Subclinical Hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-Thyroxine

The American Journal of Medicine

Volumn 82, Issue 6, 1987, Pages 1167-1170

  Ross, Douglas S ^a   Neer, Robert M ^a   Chester Ridgway, E ^a   Daniels, Gilbert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTIRELIN;

BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS THYROID SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OSTEOPENIA; OSTEOPOROSIS;

ADULT; BONE DISEASES, METABOLIC; COMPARATIVE STUDY; DEPRESSION, CHEMICAL; FEMALE; HUMAN; HYPERTHYROIDISM; PITUITARY GLAND; SUPPORT, U.S. GOV'T, P.H.S.; THYROID GLAND; THYROXINE; TIME FACTORS;

EID: 0023624938     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(87)90219-1     Document Type: Article

References (30)

1. Bony manifestations of thyrotoxicosis
2. Cases showing osteoporosis due to decalcification in exopthalmic goiter
3. Hyperthyroidism and calcium metabolism
4. Thyroid supplements: effect on bone mass
5. Exogenous hyperthyroidism with osteoporosis
6. Elevated serum thyroxine concentration in patients receiving “replacement” doses of levothyroxine
7. Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine
8. Thyroxine replacement treatment: clinical judgement or biochemical control?
9. Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for “tissue thyrotoxicosis.”
10. Elevated plasma glutathione S-transferase concentrations in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage
11. Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling
12. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule
13. Serum triidothyronine uptake using coated charcoal in assessment of thyroid function
14. A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyrotrophin releasing hormone test?
15. Measurement of bone mineral in vivo: an improved method
16. Precision and accuracy of bone mineral determination by direct photon absorptiometry
17. Multiple comparisons
18. Primary hypothyroidism
19. Bone loss in hypothyroidism with hormone replacement
20. Spinal bone mineral content in myxoedema and thyrotoxicosis
21. Replacement dosage of 1-thyroxine in hypothyroidism
22. Potency of levothyroid products
23. L-thyroxine dosage: a reevaluation of therapy with contemporary preparations
24. Bone loss in premenopausal and postmenopausal women
25. Bone mineral content in relation to age and menopause in middle-age women
26. Thyroid-pituitary interaction
27. Relationships between circulating and intracellular thyroid hormones: physiologic and clinical implications
28. Bone mineral content in hyperthyroid patients after combined medical and surgical treatment
29. Effect of hyperthyroidism and its treatment on bone mineral content